Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years. - Wikidata - awgldk - TriplyDB

Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years.

Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years.

http://www.wikidata.org/entity/Q37350944

about

Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis)Self management programme for ankylosing spondylitis Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis)Golimumab in radiographic and nonradiographic axial spondyloarthritis: a review of clinical trials Old and new treatment targets in axial spondyloarthritis Impact of inflammation on the osteoblast in rheumatic diseases Treatment of juvenile idiopathic arthritis: a revolution in care Should axial spondyloarthritis without radiographic changes be treated with anti-TNF agents?Increase in Dickkopf-1 Serum Level in Recent Spondyloarthritis. Data from the DESIR Cohort.Bone morphogenetic protein 6 polymorphisms are associated with radiographic progression in ankylosing spondylitis.Advances in managing ankylosing spondylitis Measurement and treatment of radiographic progression in ankylosing spondylitis: lessons learned from observational studies and clinical trials.Ankylosing spondylitis: patterns of radiographic involvement--a re-examination of accepted principles in a cohort of 769 patients.Ankylosis in ankylosing spondylitis: current concepts.Spondyloarthritides: evolving therapies Efficacy of etanercept on rheumatic signs and pulmonary function tests in advanced ankylosing spondylitis: results of a randomised double-blind placebo-controlled study (SPINE).Spondyloarthritis in a pediatric population: risk factors for sacroiliitis.Relationship between active inflammatory lesions in the spine and sacroiliac joints and new development of chronic lesions on whole-body MRI in early axial spondyloarthritis: results of the ESTHER trial at week 48.Higher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohort.Ultrasonography and color Doppler of proximal gluteal enthesitis in juvenile idiopathic arthritis: a descriptive study.Spinal radiographic progression in patients with ankylosing spondylitis treated with TNF-α blocking therapy: a prospective longitudinal observational cohort study.The role of IL-1β in the bone loss during rheumatic diseases.Maintenance of improvement in spinal mobility, physical function and quality of life in patients with ankylosing spondylitis after 5 years in a clinical trial of adalimumab Treatment of a mouse model of ankylosing spondylitis with exogenous sclerostin has no effect on disease progression.Impact of Dose Tapering of Tumor Necrosis Factor Inhibitor on Radiographic Progression in Ankylosing Spondylitis.The effect of three years of TNFα blocking therapy on markers of bone turnover and their predictive value for treatment discontinuation in patients with ankylosing spondylitis: a prospective longitudinal observational cohort study.ERAP1 genetic variations associated with HLA-B27 interaction and disease severity of syndesmophytes formation in Taiwanese ankylosing spondylitis.IL-23/Th17 axis is not influenced by TNF-blocking agents in ankylosing spondylitis patients Low sclerostin levels: a predictive marker of persistent inflammation in ankylosing spondylitis during anti-tumor necrosis factor therapy?Wnt/β-catenin signaling plays a key role in the development of spondyloarthritis.Association Between Dentin Matrix Protein 1 (rs10019009) Polymorphism and Ankylosing Spondylitis in a Chinese Han Population from Shandong Province.Scoring radiographic progression in ankylosing spondylitis: should we use the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) or the Radiographic Ankylosing Spondylitis Spinal Score (RASSS)?Long-term safety and efficacy of etanercept in the treatment of ankylosing spondylitis.TNF-α Promoter Polymorphisms Predict the Response to Etanercept More Powerfully than that to Infliximab/Adalimumab in Spondyloarthritis.The role of adalimumab in rheumatic and autoimmune disorders: comparison with other biologic agents Inhibition of Complement Retards Ankylosing Spondylitis Progression Quantitative syndesmophyte measurement in ankylosing spondylitis using CT: longitudinal validity and sensitivity to change over 2 years.Quantitative measurement of syndesmophyte volume and height in ankylosing spondylitis using CT.A proof-of-concept study with the tyrosine kinase inhibitor nilotinib in spondyloarthritis.Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force.

P2860

Q24186403-12FA369F-3528-4432-9B58-9D72A0A3ED6D Q24187492-5B60A8E4-587D-4D90-B855-1D5B2F29D05A Q24201300-664123DF-EF70-4688-B4E8-BA8CC7C762B0 Q26738520-5C4F4F65-28F7-42FC-AAEA-AA54D3215D5E Q26777906-E8E22795-03DA-4948-83B0-BB1512F4E04D Q26829246-96C53A67-2193-4319-9C41-6190571D7AAF Q26849497-27A20C3E-1EEC-42E3-90B9-2D9BEC38D535 Q30239856-400C8C0A-256F-4D14-8363-9FE407E576B7 Q30990351-5EFDAF8A-07B2-4C83-A0C6-5F643975F8CA Q34046853-DD723C01-1F0B-418E-846B-328E0C7B0956 Q34201927-50A015C3-5386-4D12-894A-BBCC7EE883CF Q34403448-CE6F2F41-FAF6-42FE-9D2E-8DCDEE173FF5 Q34436388-9C2FAF9A-0C24-4E76-BC38-A26A102290FE Q34474761-2B8AF953-FACB-4F12-AF43-8AEDAC717B9D Q34613907-9604C948-3521-4FEE-BFC5-1470E369FFB7 Q34758808-968E0772-D546-4936-BC9C-7D9E2C65E93C Q34976782-8B9681A7-C7D7-4BD7-B05A-F02786791876 Q35012163-65131924-0547-4E28-B19C-DDDC2BC4F463 Q35165774-340D8004-4702-4768-B76E-95AB7B35C169 Q35225836-C3BEC2F1-355E-4C3B-8A83-569722C16222 Q35449032-23AA779B-39D5-483F-9EF6-09ED1C4170A6 Q35540844-9AF1FD60-ABFB-4BDD-A863-C56C1C0C0783 Q35759171-2C138F38-D5A4-4A09-9EF7-2377F9C48AE4 Q35854185-8E95C0FF-5A0E-44C2-8EDE-206E9401BC57 Q36235821-42FFBB19-3611-4232-96F6-FCFE2BD2E09F Q36245903-0DDC7C47-A4C0-4BDF-BA7B-08F00B0DD732 Q36246044-1A4304AA-1A0D-4ED5-831D-BE1BB8612039 Q36611562-816C1DB7-D9F2-4F46-B26B-02F9A9EC40D5 Q36633205-DB34E8F8-A61C-47BC-A8D5-57338B54E367 Q36717343-A2F46CD8-01D8-4BE6-8CAE-40A7A5388271 Q36719965-50D8D8B5-5F43-4185-9062-4F180445C9FE Q36903420-9F577976-27A4-4ABE-B115-85B000575F9D Q37215981-D3896F5F-DFAE-4CFD-A574-AF79B25681F3 Q37220061-9E3FA2B4-5D70-4C42-A741-127C03C9460A Q37301134-460CAA85-BF20-42B8-96AB-727B9195EF2F Q37307003-ABE752F6-8BDC-4066-B82F-02FF3363A2D8 Q37348736-71AFF1F7-BC18-4BB9-BD92-24AD9B60B12D Q37352580-5C62C7CF-2303-40D7-A6E5-0976E2FAF645 Q37369583-52613AD3-4B45-4259-AFA9-8A42EBD62B8E Q37465518-6388447B-1EA3-417D-8D4E-7506DCE2934A

P2860

Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years.

http://www.wikidata.org/entity/Q37350944

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 24 August 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Assessment of radiographic pro ...... adalimumab for up to 2 years.

@en

Assessment of radiographic pro ...... adalimumab for up to 2 years.

@nl

type

label

Assessment of radiographic pro ...... adalimumab for up to 2 years.

@en

Assessment of radiographic pro ...... adalimumab for up to 2 years.

@nl

prefLabel

Assessment of radiographic pro ...... adalimumab for up to 2 years.

@en

Assessment of radiographic pro ...... adalimumab for up to 2 years.

@nl

P1433

Q37350944-24876423-C0E9-4BA2-96AE-59799D2B8434

P1476

Q37350944-31817A92-8CB5-418E-B702-164A168B8064

P2093

Q37350944-2B64755C-9499-49C4-976F-7321E538F30E

Q37350944-31848FF6-2645-40FA-A9A7-8EDFCA891AB4

Q37350944-539100BF-DF0F-4DB5-89CD-60CEC769C109

Q37350944-B2B5386B-9DDC-425A-A499-2DACF7CDCE3A

Q37350944-DA0C7072-689E-4B3F-8329-7FAE20A7B7E7

Q37350944-FA97AC8A-69EB-4F90-87AD-63109DF03A86

Q37350944-FE7FE639-75C8-462A-A5D9-2C457AD208FF

Q37350944-FF238E03-D6E7-4DAE-9866-3ED1EED2488E

P2860

Q37350944-02AD39D7-22F6-4030-9A2F-CA99B01ABDF6

Q37350944-10608A11-6773-4B54-B87C-D4C55A99AAB3

Q37350944-16876E07-060B-49F3-86DB-BF368FAAE9B8

Q37350944-53E2EF83-8DAD-4BBE-93A8-E886B56E5AC9

Q37350944-5D6BF5C2-1462-4D46-BF3C-D6C143F5AB63

Q37350944-5EE3A635-C206-4289-9EF3-D0F59243144F

Q37350944-65E6627F-19D9-4DA5-8476-26B5C0241986

Q37350944-6C6D0CC6-BD0C-46FA-BE8D-7E246FA6095A

Q37350944-7306D9A4-595D-47B8-9B42-7363837B44D9

Q37350944-755202B1-0C3E-4DD2-A2A5-8934CD8BAC96

P2888

Q37350944-439E101E-E788-4B99-BD9E-2048D73F6AEE

P304

Q37350944-3A049168-7475-458B-AEE0-1717357E0B26

P31

Q37350944-E1C80162-A6E6-4580-B8EA-89AC5C293F31

P356

Q37350944-B9523393-E0D6-49FA-9880-2148F686DB48

P433

Q37350944-CBAAE43F-C9A5-47C8-A733-8E34FE50E3F6

P478

Q37350944-A3E0D3D8-8E80-4C40-A858-13E6FDD60265

P50

Q37350944-9D9A14DC-33A8-4878-B150-A4A11C06A6FC

Q37350944-A2AAABFE-D41B-4AFF-A480-88D25C06A8EF

Q37350944-D4DB0B16-31DF-4BD3-B14F-87131D246A88

P577

Q37350944-AB4D0B95-986D-4105-805C-62E1F961C054

P5875

Q37350944-3C704D46-586B-4818-853E-6FD5BD477DA7

P6179

Q37350944-C4274F71-D61E-4E5D-9E03-79A3C5EB1524

P698

Q37350944-E76BAC41-72B3-4916-805D-475CB857985E

P921

Q37350944-8DFF161E-5A55-40FB-97F2-E9650A9C1B44

Q37350944-DC4C4E36-9386-4FDF-8FBF-5C36851B79CC

P932

Q37350944-4513A0E4-88FC-4B0C-9E18-29281FC9B7AB

P356

P1433

Arthritis Research and Therapy

P1476

Assessment of radiographic pro ...... adalimumab for up to 2 years.

@en

P2093

ATLAS study group

http://www.w3.org/2001/XMLSchema#string

Barbara N Weissman

http://www.w3.org/2001/XMLSchema#string

Canadian (M03-606) study group

http://www.w3.org/2001/XMLSchema#string

David Salonen

http://www.w3.org/2001/XMLSchema#string

Eric Gibson

http://www.w3.org/2001/XMLSchema#string

Hartmut Kupper

http://www.w3.org/2001/XMLSchema#string

Robert Wong

http://www.w3.org/2001/XMLSchema#string

Shaila Ballal

http://www.w3.org/2001/XMLSchema#string

P2860

Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis.

Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-cont

Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial.

Osteoclasts are essential for TNF-alpha-mediated joint destruction.

Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis.

Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system.

A longitudinal study on an autoimmune murine model of ankylosing spondylitis.

Association between radiographic damage of the spine and spinal mobility for individual patients with ankylosing spondylitis: can assessment of spinal mobility be a proxy for radiographic evaluation?

How should treatment effect on spinal radiographic progression in patients with ankylosing spondylitis be measured?

P2888

P304

R127

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/AR2794

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Désirée van der Heijde

Robert Landewé

Walter P Maksymowych

P577

2009-08-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

228517159

http://www.w3.org/2001/XMLSchema#string

P6179

1043333542

http://www.w3.org/2001/XMLSchema#string

P698

19703304

http://www.w3.org/2001/XMLSchema#string

P921

P932

2745811

http://www.w3.org/2001/XMLSchema#string